Department of Ophthalmology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001 Heilongjiang Province, China.
Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 Heilongjiang Province, China.
Dis Markers. 2022 May 29;2022:6900660. doi: 10.1155/2022/6900660. eCollection 2022.
: For studying the association of EPO (rs551238), EPO (rs1617640), and TCF7L2 (rs7903146) gene with diabetic retinopathy in Northern Chinese population. : We conducted a case-control study, which enrolled 680 subjects and performed SNP genotyping and calculated allele frequencies. : When comparison was performed between DR patients and normal persons, the EPO (rs551238) AA genotype has a significant risk association with DR, and AC genotype has a significant protective association with DR. The EPO (rs551238) A allele has a significant risk association with DR, and C allele has a significant protective association with DR. When comparison was performed between DR patients and DM patients, the EPO (rs551238) CC genotype has a significant protective association with DR; the EPO (rs551238) A allele has a significant risk association with DR; and C allele has a significant protective association with DR. When comparison was performed between DR patients and normal persons, the EPO (rs1617640) GT genotype has a significant protective association with DR, and TT genotype has a significant risk association with DR. The EPO (rs1617640) G allele has a significant protective association with DR, and T allele has a significant risk association with DR. In addition, we found that TT genotype does not exist in rs7903146 of TCF7L2 in Chinese population so that the data could not be used. : EPO (rs551238, rs1617640) genotype is a susceptible gene for DR in Chinese type 2 diabetic patients, especially the high-risk PDR.
为了研究 EPO(rs551238)、EPO(rs1617640)和 TCF7L2(rs7903146)基因与中国北方人群糖尿病视网膜病变的关联。
我们进行了一项病例对照研究,纳入了 680 名受试者,并进行了 SNP 基因分型和计算等位基因频率。
当将 DR 患者与正常个体进行比较时,EPO(rs551238)AA 基因型与 DR 有显著的风险关联,AC 基因型与 DR 有显著的保护关联。EPO(rs551238)A 等位基因与 DR 有显著的风险关联,C 等位基因与 DR 有显著的保护关联。当将 DR 患者与 DM 患者进行比较时,EPO(rs551238)CC 基因型与 DR 有显著的保护关联;EPO(rs551238)A 等位基因与 DR 有显著的风险关联;C 等位基因与 DR 有显著的保护关联。当将 DR 患者与正常个体进行比较时,EPO(rs1617640)GT 基因型与 DR 有显著的保护关联,TT 基因型与 DR 有显著的风险关联。EPO(rs1617640)G 等位基因与 DR 有显著的保护关联,T 等位基因与 DR 有显著的风险关联。此外,我们发现中国人 EPO(rs551238,rs1617640)TCF7L2 基因的 TT 基因型不存在,因此无法使用该数据。
EPO(rs551238,rs1617640)基因型是中国 2 型糖尿病患者 DR 的易感基因,尤其是高危 PDR。